Compared to the mock control group, the TRIM8-transfected group exhibited a 2.7-fold decrease in tumour weight (Fig. 5A), but subcutaneous tumour growth was not different between the A549 and H358 cells (Fig. 5A). Here, TRIM8 is linked to neoplasm.